Ocular hypotensive efficacy of a new liposomal latanoprost formulation administered by different routes for experimental ocular hypertension

• Autori principali: I. M. Mikheytseva (Autore), G. S. Grygorieva (Autore), N. V. Pasyechnikova (Autore), S. G. Kolomiichuk (Autore), T. I. Siroshtanenko (Autore), N. F. Konakhovych (Autore)
• Natura: Libro
• Pubblicazione: Ukrainian Society of Ophthalmologists, 2022-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Prostaglandin analogs (e.g., latanoprost) are the first-line therapy for glaucoma. These medications, however, have a short antihypertensive effect due to low penetration of topical drug across the corneal epithelium, which causes the need for their daily application for a long time. The...